For over 30 years we have helped our clients get their new and innovative drug treatments into the hands of those who need them most by simplifying the journey to market. We are committed to solving problems before they arise, to making the process smarter and more efficient, and to being a true partner to our clients, in every sense.
Watch our new video




Explore More
Explore More
Explore More
Explore More
Explore More
Explore More

Latest News

PAREXEL International Announces Date of Fourth Quarter and Fiscal Year 2014 Earnings Release and Conference Call

Boston, MA, July 10, 2014 – PAREXEL International Corporation (NASDAQ: PRXL) will release financial results for the Fourth Quarter and Fiscal Year 2014 on Wednesday, August 6th, 2014 after the close of the stock market. 

PAREXEL Insights

Clinical Trial Feasibility and Patient Enrollment: Differentiation Through Innovation 

by Paul Evans, PAREXEL Vice President, Feasibility and Enrollment Solutions 

Biopharmaceutical companies continue to explore ways to make clinical trials more efficient and effective at each phase of the drug development journey.  This is especially the case when it comes to trial feasibility and patient enrollment.  

Linkedin Updates


See the future of clinical trials: Read Accelerating the Clinical Development Journey with Improved Data Management

Make clear, concise eClinical decisions. Learn more about data-driven monitoring.

While PAREXEL has cultivated best practices from deep experience, we also know the value of jointly designing a process.  It’s not only about doing what works, it’s about finding what works best for each client.

At PAREXEL we are driven to solve the complex.  Our mission is to prepare your science for the real world by simplifying your journey at every step.

Today, a global footprint is no longer enough.  Biopharmaceutical companies need the intelligence that only a truly integrated global network can provide.